Tech Company Financing Transactions
NRG Therapeutics Funding Round
NRG Therapeutics, based in Stevenage Herts, secured $18.9 million in investment from Omega Funds, Brandon Capital Partners and Parkinson's Virtual Biotech.
Transaction Overview
Company Name
Announced On
11/9/2022
Transaction Type
Venture Equity
Amount
$18,900,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to advance its first-in-class brain-penetrant small molecules through IND-enabling studies.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Stevenage Bioscience Catalyst Gunnels Wood Road
Stevenage Herts, SG1 2FX
UK
Stevenage Herts, SG1 2FX
UK
Phone
Undisclosed
Website
Email Address
Overview
NRG Therapeutics is passionate about bringing new medicines and hope to the growing number of people worldwide living with debilitating neurodegenerative disorders. A neuroscience-focussed drug discovery company building a pipeline of disease modifying drug candidates, NRG Therapeutics is focused on therapeutic approaches that will restore mitochondrial function and slow or halt the progression of neurodegenerative diseases such as Parkinson's and Amyotrophic Lateral Sclerosis, ALS (also known as motor neurone disease, MND).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Neil Miller
Chief Operating Officer
Grant Hawthorne
Co-Founder
Anthony Rutter
Browse more venture capital transactions:
Prev: 11/9/2022: Antavo venture capital transaction
Next: 11/9/2022: Something & Nothing venture capital transaction
Share this article
News on VC Transactions
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs